Objective: The two-to fourfold higher risk of cardiovascular disease in diabetes mellitus is more strongly predicted by the postprandial than by the fasting blood glucose and lipids. We aimed to investigate the impact of postprandial changes in serum lipoprotein fractions on lipid peroxidation in type I diabetes mellitus (T1DM). Design: This was a prospective observational study. Setting: The study was performed at Antwerp University Hospital, Belgium. Subjects: Twenty-three well-controlled T1DM patients were included. Intervention: Patients received a standard breakfast and lunch (450% energy as fat). Blood was sampled at fasting (F), after the post-breakfast hyperglycemic peak (BP), just before lunch (B), after the post-lunch hyperglycemic peak (LP), after the post-lunch dale (LD) and 5 h after lunch (L) for the measurement of serum lipids, lipoprotein subfraction composition, a-tocopherol and lipid peroxidation in vivo and in vitro. Results: Serum triacylglycerols (Tgs) increased (from 1.0370.40 at F to 1.6070.87 mmol/l at LP, P ¼ 0.001), but cholesterol decreased by 12% in parallel with a-tocopherol (from 4.4370.76 at F to 4.1270.82 mmol/mmol total lipid at B, P ¼ 0.006). Although plasma malondialdehyde increased from 1.0270.36 at F to 1.1470.40 mmol/L at LP, P ¼ 0.03, copper-induced in vitro peroxidation decreased in the low-density lipoprotein and high-density lipoprotein fractions. Conclusions: In well-controlled T1DM patients moderate postprandial increases in serum Tgs are accompanied by a relative deficiency in a-tocopherol. Lipid peroxidation in vivo increases but cannot be ascribed to changes in the susceptibility of lipoproteins to copper-induced in vitro peroxidation.
Introduction
The two-to fourfold higher risk and mortality from cardiovascular disease (CVD) in diabetes mellitus is partly explained by the typical abnormalities of plasma lipid and lipoprotein metabolism (Syvanne and Taskinen, 1997) as well as by the various pathobiochemical consequences of hyperglycemia (Brownlee, 2001) . Studies conducted mainly on type II diabetic patients (T2DM) demonstrate that postprandial changes in blood glucose and lipids are more strongly associated with cardiovascular risk than the fasting values (Zilversmit, 1979; Temelkova-Kurktschiev et al., 2000; Teno et al., 2000) .
The pathobiochemical mechanisms mediating the proatherogenic events during the postprandial phase are not fully understood. The theory of oxidative stress (OS) (Ceriello, 2000) stems from increases in markers of oxidative damage to lipids such as thiobarbituric acid reactive substances (Ceriello et al., 1998) and F2 isoprostanes (Sampson et al., 2002) , which have been documented in the 2-3 h after an oral glucose tolerance test (OGTT). However, the conclusions from OGTT studies cannot be extrapolated to the more complex situation of the postprandial state caused by the ingestion of a meal. Several observations suggest that after a meal there may be additional sources of free radicals that might contribute to the postprandial OS independently or in synergism with the postprandial increases in blood glucose. For example, postprandial increases in triacylglycerols (Tgs), non-esterified fatty acids and more specifically in long-chain fatty acyl coA can also lead to higher release of free radicals by the mitochondrial respiratory chain (Bakker et al., 2000) and thus further increase OS (Ceriello et al., 2002) . Moreover, the impact of meal-associated changes in the oxidant-antioxidant balance has not been evaluated yet. This can range from increases due to ingestion of the antioxidants contained in the meal to decreases due to the consumption caused by the postprandial release of free radicals.
Most of the studies on postprandial pathology cited above have been conducted on T2DM patients or in subjects with the metabolic syndrome. In type I diabetes mellitus (T1DM), cardiovascular risk is also increased (by four-to ninefold) (Koivisto et al., 1996) and more than a third of these patients die of CVD (Krolewski et al., 1987; Laing et al., 2003) . However, some of the universally accepted CVD risk factors differ in the two groups and it is not known whether the underlying mechanisms are unique to T1DM or the same as for the general population and T2DM. In T1DM fasting dyslipidemia is characterized by less pronounced hypertriglyceridemia and low high-density lipoprotein (HDL) cholesterol and less prevalent small dense low-density lipoprotein (LDL) particles (Manuel-y-Keenoy et al., 2003 , 2004b , but the clearance and composition of postprandial lipoproteins is abnormal (Georgopoulos and Phair, 1991) and potentially atherogenic by promoting cholesterol accumulation in macrophages (Klein and Lyons, 1989) .
As a result, the atheroma plaques from these patients contain similar amounts of lipids, macrophages and thrombus as in non-insulin-dependent diabetic patients and higher amounts than in non-diabetic patients (Moreno et al., 2000) .
Because these abnormalities are intricately related to the degree of glycation and the triglyceride content in lipoproteins, it can be hypothesized that the excessive increases in blood glucose and lipids occurring in the postprandial phase can, by altering their composition and increasing peroxidation, increase atherogenicity.
To gain more insight into this question, we aimed to describe the time course of postprandial and postabsorptive changes in serum lipids and lipoprotein subfractions and to investigate whether they were related to changes in a-tocopherol and in vivo and in vitro lipid peroxidation in subjects with T1DM. The accompanying changes in blood glucose and in oxidant/antioxidant balance have been described elsewhere (Manuel-y-Keenoy et al., 2004a , 2005 .
Materials and Methods

Study subjects
Type I diabetic patients on intensive insulin treatment (basal bolus regime with X4 injections daily) were asked to take part in the study. Exclusion criteria were o18 and 469 years of age, body mass index (BMI) o 20 and 430 kg/m 2 , detectable C-peptide, pregnancy, alcohol or drug abuse, abdominal, renal or hepatic disease, anemia, low platelet count, clotting disorders and glycated hemoglobin 49%. The patient characteristics are shown in Table 1 . Three male . With respect to fasting serum lipids, 13 patients had total cholesterol 4.86-6.10 mmol/l, three had HDL 1.09-1.18 mmol/l and two had Tgs 1.75-1.84 mmol/l. The complication profile included no antecedents of CVD, nine patients with mild background retinopathy and four with neuropathy. Albuminuria ranged from 0 to 100 mg/min (median 6.2 mg/min). Five men and nine women used insulin analogues (Novorapid or Humalog) and six took angiotensin-converting enzyme (ACE) inhibitors. Except for 1 patient treated with fenofibrate, they were receiving no lipidlowering medication.
After the informed consent form was signed, each patient was hospitalized in the metabolic ward. On the evening before the test, a continuous glucose monitoring device (GlucoDay, A. Menarini Diagnostics, Florence, Italy) was inserted subcutaneously and blood glucose values were registered every 3 min. Patients were asked not to modify their self-glucose monitoring and insulin dosages. This is based on increasing insulin by 1 unit per carbohydrate portion and per 50 mg/dl increase in preprandial capillary glucose above 100 mg/dl. They received a standard breakfast (883 Kcal, 31 and 12% energy as carbohydrates and proteins, respectively) rich in fats, especially in saturated fats (33% energy, with 17 and 8% energy as monounsaturated and polyunsaturated fats, respectively) and containing about 4 mg vitamin E (a-tocopherol equivalents) and 226 mg retinol. The standard lunch (698 Kcal, 28 and 22% energy as carbohydrates and proteins, respectively) contained 16, 21 and 12% energy as saturated, monounsaturated and polyunsaturated fats, respectively, and about 2 mg vitamin E and 237 mg retinol.
By monitoring subcutaneous glucose online via an infrared port, the post-breakfast and post-lunch blood glucose peaks and dales were immediately identified. Blood samples were extracted at fasting (F), just after (with a maximum interval of 10 min) the post-breakfast peak (BP), 3.5 h after starting breakfast and just before lunch (B), just after the post-lunch peak (LP), just after the post-lunch dale (LD) and 5 h after lunch (L).
The experimental protocol was in accord with the Helsinki declaration and was approved by the ethical commission of the University Hospital.
Analytical methods
Subcutaneous glucose was transformed into plasma glucose values by comparison of the subcutaneous and intravenous data obtained at 7-9 points in time during the course of the test.
Routine blood tests including serum total cholesterol, HDL-cholesterol, and Tgs were analyzed in the laboratory of Antwerp University Hospital. Total analytical variability, expressed as a coefficient of variation (CV) was 2, 1.9 and 0.9%, respectively. LDL-cholesterol was calculated according to Friedewald's equation (Friedewald et al., 1972) . Glycated hemoglobin (HbA 1c ) was measured using a high-performance liquid chromatography (HPLC) cation exchange column (Modular Diabetic Monitoring System; Bio-Rad, Richmond, CA, USA); the CV was 1.5%.
Plasma concentrations of a-tocopherol were measured by HPLC (Shimadzu, Kyoto, Japan) with a reversed phase C18 column LiChrospher RP C18 (Alltech, Deerfield, IL) with 100% methanol mobile phase and detection at 292 (Caye-Vaugien et al., 1990 ) with a CV of 4.8%.
Plasma malondialdehyde (MDA) was analyzed by HPLC using reversed phase LiChrospher RP C18 (Alltech, Deerfield, IL, USA), methanol/KH 2 PO 4 10 mM (40/60 v/v) as mobile phase and detection at 532 nm (Nielsen et al., 1997) ; CV was 9%.
Nine lipoprotein subfractions were obtained from fresh plasma anticoagulated with ethylene diamine tetraacetic acid (EDTA) (kept at 41C for o 9 h) by sequential density gradient ultracentrifugation according to the method of Karpe (Karpe and Hamsten, 1994) . The average density in each fraction was as follows: chylomicron (density o 0.95 g/ml); very-low-density lipoprotein (VLDL1, density 1.006, and VLDL2, 1.0114 g/ml); intermediate-density lipoprotein (IDL 1.0185 g/ml); LDL (LDL1 1.0298, LDL2 1.0434 and LDL3 1.0639 g/ml); HDL (HDL1 1.0761 and HDL2 1.0851 g/ml). Lipid composition of pooled lipoprotein fractions was immediately analyzed using commercial kits for the determination of total cholesterol (CHOD-PAP kit, Merck, Germany), Tgs (GPO-Trinder kit, Sigma Diagnostics, St Louis, MO, USA) and phospholipids (PAP 150, BioMérieux, Lyon, France). Isolated fractions were stored at À801C for 3-6 months before analysis of in vitro peroxidation. These lipoprotein suspensions contained about 2 mM EDTA, necessary to prevent peroxidation and consumption of endogenous antioxidants during storage. After fractions were thawed, the EDTA and salt in each lipoprotein fraction were removed by filtration (Vivaspin filters 10 kDa cutoff) at 6000 r.p.m. for 20 min. The desalted lipoprotein was resuspended in 4% PBS, pH 7.0, at a protein concentration of 240 mg/ml. After the addition of copper sulfate (50 mmol/l) the formation of fluorescent products of peroxidation was monitored at 371C for 4 h at emission/excitation of 360/440 nm in a fluorescence well-plate reader (Fluoroskan Ascent, ThermoLabsystems, Helsinki, Finland). This in vitro peroxidation experiment was carried out simultaneously in all lipoprotein subfractions obtained at the three time points from each patient. CVs of the fluorescence parameters ranged from 5 to 9% (Zhang et al., 1994) .
Statistical analysis
Data were analyzed using SPSS software (version 11.0, Chicago, IL, USA). Results are expressed as means7s.d. or s.e.m. where indicated and two-tailed P values o 0.05 were considered significant. Between-group comparisons at baseline were performed by t-test or Mann-Whitney test for the non-gaussian variables. The changes in the various parameters were analyzed by repeated measures analysis of variance (ANOVA) and Friedman's test. Data were analyzed for change during the course of the day (within-subject comparison). The evolution of these time-related changes was compared in the various subgroups of subjects by introducing between-subject factors (male versus female, smoker, etc) in the statistical model (between subject-group comparison). Analysis of contrasts was applied to identify the significance of the change when compared with the fasting value and with the value obtained in the preceding time point.
Results
Fasting serum Tgs correlated positively with daily insulin dose (r ¼ 0.57, P ¼ 0.007) and plasma a-tocopherol (r ¼ 0.42, P ¼ 0.048). Plasma a-tocopherol also correlated with serum cholesterol (r ¼ 0.57, P ¼ 0.004). Fasting HDL cholesterol tended to correlate negatively with fasting Tg (r ¼ À0.38, P ¼ 0.08) and BMI (r ¼ À0.37, P ¼ 0.09).
There were big inter-individual differences in postprandial glucose changes but with clear BP and LP hyperglycemic peaks reaching concentrations of 3137105 and 3047119 mg/dl, respectively, ns. Three to four hours after the postlunch peak, there was a clear postabsorptive (LD and L) decrease in blood glucose to 85757 mg/dl.
The changes in serum lipids followed differing patterns (Figure 1a ). Total cholesterol decreased by 12% in BP and 11% in B (Po0.0005 vs the fasting value), was maintained low throughout the post-lunch peak and dale and returned to the fasting values only in the postabsorptive phase (L). The time course of postprandial HDL changes evolved in parallel, with a 12.6% decrease in B, but the restoration in Values were monitored at fasting (F), just after the post-breakfast glucose peak (at 1.470.2 h), just before lunch (B), just after the post-lunch glucose peak (LP) (at 4.170.3 h), just after the post-lunch glucose dale (LD) (at 7.270.2 h) and 5 h after lunch (L). Shown are means7s.e.m. of 23 patients. The P-value denoting the significance of the overall change over time, calculated by repeated measures ANOVA, was o 0.0005 for cholesterol, 0.037 for Tg, 0.005 for a-tocopherol and 0.12 for MDA. *Po0.05 when contrasted to the value at fasting; y, Po0.05 when contrasted to the preceding value. (Figure 1b) decreased from 26.076.7 mmol/l at F to 24.375.0 mmol/l at BP (P ¼ 0.010), decreased further 3.5 h after breakfast B (23.175.5 mmol/l) and then remained low till LD and returned to values similar to fasting values in the postabsorptive phase L (25.075.6 mmol/l, ns from F). Even when expressed relative to total lipids (Tg þ cholesterol), a-tocopherol decreased from 4.4370.76 mmol/mmol lipid at F to 4.1270.82 at B (P ¼ 0.006) and then returned to 4.4370.82 mmol/mmol lipid at L (ns from F). Relative to total cholesterol, in contrast, there was no significant change, with levels at F (5.3171.11 mmol a-tocopherol/mmol cholesterol) being maintained throughout the study period. Indeed, the total AUC for a-tocopherol correlated with that of cholesterol (r ¼ 0.53, P ¼ 0.029) but not Tgs.
In view of the correlations between insulin dose and fasting lipids and a-tocopherol, the relationship between insulin dose and the postprandial changes in these parameters was also analyzed. The post-breakfast decrease in cholesterol (between F and BP) was more pronounced in patients injecting more insulin (total daily dose). This association was explained by the positive correlation with the dose of slow insulin (r ¼ 0.57, P ¼ 0.04) in contrast to the lack of significant correlation with the dose of rapid-acting insulin (r ¼ À0.37, P ¼ 0.13). There was no correlation between insulin dose at lunch and post-lunch changes (between B and LP) (r ¼ À0.13, P ¼ 0.67). Surprisingly, in the patients injecting more rapid insulin at breakfast the total decrease in cholesterol between fasting and the postlunch peak (between F and LP) was less pronounced (r ¼ À0.60, P ¼ 0.03) and the AUC for Tgs was larger (r ¼ 0.56, P ¼ 0.02). Insulin dose was not related to the decrease of a-tocopherol during any of the postprandial periods (post-breakfast, post-lunch and between breakfast and lunch).
Use of insulin analogues or ACE inhibitors, smoking and gender did not affect total insulin dose or changes in lipids and tocopherol. BMI correlated positively with insulin dose (r ¼ 0.51, P ¼ 0.02) and uric acid at fasting as well as its AUC (r ¼ 0.52, P ¼ 0.04) but not with lipid levels or changes.
In vivo lipid peroxidation was monitored by measuring plasma MDA, which increased gradually from 1.0270.36 mmol/l at F to a maximum of 1.1470.40 mmol/l at LP (P ¼ 0.028) and then decreased to 0.9270.29 mmol/l at L (P ¼ 0.044 compared to F; P ¼ 0.12 for the overall change in time) (Figure 1b) . The overall change in time was statistically significant (P ¼ 0.029) when correcting for the total concentration of peroxidizable substrate (added molar concentration of cholesterol þ Tg) with increases at B and LP and a significant decrease from LD to L (P ¼ 0.023). The AUC for MDA was higher in older patients (r ¼ 0.56, P ¼ 0.009) and in patients not using insulin analogues (P ¼ 0.01) and tended to be higher in men (P ¼ 0.06). It did not correlate with changes in a-tocopherol.
Lipoprotein subfractions were obtained from blood samples at F, B and L. Tg, cholesterol and phospholipid content was measured in pooled fractions. As shown in Figure 2 , all lipids increased in the chylomicron fraction postprandially (B, 3.5 h after breakfast) and remained significantly higher than fasting in the postabsorptive phase (L, 5 h after lunch). In the pooled VLDL and IDL fractions only Tg content increased significantly in B but reverted to values similar to fasting in L. In the LDL fractions all lipids decreased in B and reverted to fasting values in L. The decrease in cholesterol content of the LDL fractions in B amounted to 11.4%. Finally, in the HDL fractions only Tgs and phospholipids decreased in B and again returned to fasting values in L.
In vitro copper-induced lipid peroxidation was monitored in each of the isolated lipoprotein subfractions, excepting the chylomicron and HDL2 fractions. As shown in Figure 3 , three phases were distinguished: (1) the lag time (expressed in min), during which fluorescence does not increase significantly; it quantifies the capacity of the antioxidants within the lipoproteins to retard the initiation of oxidation; (2) the slope of the propagation phase, during which fluorescence increases rapidly, which indicates the velocity of oxidative changes; and (3) the saturation phase during which fluorescence reaches a plateau, which gives an estimate of the total amount of lipid oxidized.
Susceptibility to peroxidation was greatest in the HDL and LDL fractions (Figure 3 ). In the VLDL1 fraction no copperinduced peroxidation was detected in about one third of the cases. The lag times and slopes were compared at F, B and L as shown in Table 2 . There was a shortening of the lag time of the VLDL fractions by 10-20 min in the postabsorptive phase (L). In contrast, although the lag time did not change significantly in the LDL and HDL fractions, the slope decreased significantly in the postprandial phase (B) and remained lower through to the postabsorptive phase.
Discussion
In this study we aimed to investigate whether postprandial changes in lipoprotein composition can enhance lipid peroxidation and thus explain, at least in part, the increased cardiovascular risk of T1DM patients. For this purpose we described a detailed time course of the changes in blood lipids, lipoprotein composition, plasma a-tocopherol content and lipid peroxidation in vivo and in vitro occurring in the 8-9 h encompassing the fasting, postprandial and postabsorptive periods in a group of well-controlled T1DM patients on intensive insulin treatment.
In our group of patients, several of the risk factors known to worsen diabetic dyslipidemia (Sibley et al., 1999; Purnell et al., 1998; Winocour et al., 1987) were absent because there was no established nephropathy and no obesity. Fasting HDL and LDL cholesterol and Tgs were acceptable without requiring lipid-lowering medication and blood pressure and glycemia were under relatively good control.
As expected after a fat-rich meal (450% energy as fat), serum Tgs increased from 1.0 at fasting to 1.6 mmol/l postprandially, with an increase in all lipid components of the chylomicron fraction and of Tgs in the VLDL fractions. This moderate increase is similar to the twofold increases seen in normal volunteers and in non-obese controls after a higher fat meal (66 energy%) but lower than in obese subjects (who had increases of up to 4 mmol/l) (Lewis et al., 1990; Schaefer, 2002) . Levels of 2.3 mmol/l reached even after a moderate-fat meal (20% energy) are associated with a higher risk of enhanced intima media thickness and of myocardial infarction in T2DM (Teno et al., 2000) . Also in contrast to T2DM where prolonged postprandial hypertriglyceridemia (peak later than 4-6 h) is the norm (Taskinen, 2003) , peak Tg was reached in less than 3 h after lunch with a return to fasting values 5 h after lunch. Other studies Postprandial lipoproteins and peroxidation in type I diabetes B Manuel-y-Keenoy et al confirm that the postprandial Tg response is not prolonged in normolipemic T1DM when compared with matched controls (Lewis et al., 1991) . The 12% postprandial decreases we observed in total and HDL cholesterol are more pronounced than the 0-5% decreases seen in healthy volunteers after a similar fat load (Cohn et al., 1988) . In obese patients similar HDL decreases (up to14%) were seen (Lewis et al., 1990) . In contrast to these studies, we did not observe a concomitant increase in Tg content in the LDL and HDL. The decrease in postprandial LDL cholesterol was only slightly overestimated using Friedewald's formula (15% vs 11% in the LDL fractions isolated by ultracentrifugation). These observations, together with the relatively high fasting HDL cholesterol levels and low Tg in our group of patients, suggest that increased CETPmediated exchange of cholesteryl esters and Tgs was not the main cause of the postprandial decrease in cholesterol levels documented in our group of T1DM patients. An alternative explanation is that exogenous insulin suppresses the inhibition of the LDL receptor by LDL, thus leading to increased clearance of LDL (Wade et al., 1988) .
The postprandial increases in blood Tgs and glucose were accompanied by a parallel increase in plasma MDA, which is one of the many end-products of lipid peroxidation, derived from polyunsaturated fatty acids with more than two double bonds such as arachidonic acid (Esterbauer et al., 1991) . Despite the fact that it represents as little as 10% of all lipid peroxidation products (Esterbauer et al., 1989) and that its clinical relevance is controversial (Gutteridge and Halliwell, 1990) , plasma levels of MDA are still currently used as a surrogate marker of in vivo lipid peroxidation (de Zwart et al., 1999) . We, among others, have observed higher fasting levels in diabetic patients and these were inversely related to levels of endogenous antioxidants such as glutathione and uric acid (Dierckx et al., 2003) and associated with poor metabolic control and cardiovascular complications (Griesmacher et al., 1995) . A postprandial increase in MDA has also been observed in T2DM patients (Ceriello et al., 1998) . Confirmation of increased in vivo peroxidation during acute hyperglycemia in T2DM patients was obtained by quantification using more sensitive and specific markers such as F2 isoprostanes (Sampson et al., 2002) . Further studies measuring diurnal F2 isoprostane changes still need to be conducted in T1DM patients.
Increased postprandial lipid peroxidation could be caused by several mechanisms. First, changes in lipid, fatty acid and antioxidant composition of the lipoproteins can lead to increased susceptibility to peroxidation. This property can be monitored by isolating the various lipoprotein fractions and exposing them in vitro to oxidants such as copper. Using this method we, among others, have shown that copper-induced production of MDA and fluorescent products is higher in fasting LDL and VLDL from T1DM than in non-diabetic subjects (Zhang et al., 1994) and that it can be affected by changes in lipoprotein composition caused, for example, by statins (Manuel-y-Keenoy et al., 2003) . Although in unsupplemented subjects serum levels of a-tocopherol do not correlate with lipoprotein peroxidability and only account for about 20% of the lipoprotein antioxidant capacity (Esterbauer et al., 1992; Frei and Gaziano, 1993) , there is ample evidence that supplementation with vitamin E results in a lowering of in vitro lipoprotein peroxidability in a wide range of subjects including T1DM patients (Engelen et al., 2000; Manuel-y-Keenoy et al., 2004b) . Evidence that antioxidant, and in particular, vitamin E depletion leads to increased peroxidation is less abundant (Winklhofer-Roob et al., 2004; Van Dam et al., 1998) . In the present study we observed postprandial decreases of water-soluble plasma antioxidants such as ascorbate and uric acid (Manuely-Keenoy et al., 2005) . Because these are present in the aqueous phase surrounding the lipoproteins, inefficient recycling of oxidized tocopherol in the lipoprotein in vivo might result (Frei et al., 1988) . This, added to the fact that an acute rise in insulin (for example, post-injection) accelerates the entry of a-tocopherol from the plasma into the cells (Galvan et al., 1996) , can lead to a less efficient antioxidant network in vivo and lowering of plasma a-tocopherol levels. However, postprandial changes in plasma MDA and a-tocopherol were not statistically related and the postprandial decrease in a-tocopherol was not accompanied by any change in the lag times for copper-induced peroxidation of LDL and HDL lipoproteins, indicating that there was no change in the antioxidant capacity of these lipoproteins. On the contrary, the slopes even decreased, suggesting a decrease in substrate (Esterbauer et al., 1989) . These observations are compatible with the decrease in cholesterol content in the LDL and HDL fractions and the preservation of the molar ratio of a-tocopherol relative to cholesterol. Increased peroxidation of the triglyceride-rich lipoproteins as the source of the postprandial increase in plasma MDA can also be ruled out because the shortening of the lag time of the VLDL fractions occurred only in the postabsorptive phase, which coincided with the return of MDA to levels lower than at fasting. A second possible cause of increased accumulation of lipid peroxidation products in vivo is an imbalance in the antioxidant/pro-oxidant ratio in favor of the pro-oxidants caused by an enhanced postprandial release. The hypothetical role of high glucose and Tgs as the main sources of the OS in the postprandial phase of this group of patients is supported by several observations. First, the time courses of MDA, glucose and Tgs evolved in parallel. The prolonged 9-h monitoring of our patients permitted us to observe that levels of MDA and a-tocopherol returned to values similar to those at fasting in the post-absorptive phase, which in these patients was characterised by a fall in blood glucose and Tgs. And last, the pattern of these time courses was not affected by factors such as sex, smoking, use of insulin analogues or ACE inhibitors.
There is convincing evidence that high glucose causes an increase in free radical production by mechanisms such as increased mitochondrial respiration and release of superoxide (Anderson et al., 2001; Nishikawa et al., 2000) , de novo synthesis of diacylglycerol (Idris et al., 2001 ) and activation of protein kinase C (Koya et al., 1997) . One of the many consequences of this activation is exaggeration of the respiratory burst by monocytes, which has been shown to increase in the postprandial phase (Mohanty et al., 2002) .
It has recently been postulated that postprandial increase of Tgs and subsequently of intracellular long-chain fatty acids leads to the accumulation of electrons in the mitochondrial transfer chain, thus forming an additional important source of free radicals in the post-meal period (Scheffer et al., 2001; Heine and Dekker, 2002) .
Two additional sources of pro-oxidants in the postprandial period that require further investigation are the foodstuffs ingested and, in the case of T1DM patients, injections of insulin. Meal content can be pro-oxidant because of the presence of oxidized lipids (Staprans et al., 1999) , advanced glycation end-products (Ceriello, 2000) and oxidizable lipids. Insulin increases hydrogen peroxide production by adipocytes (Krieger-Brauer and Kather, 1992; Paolisso and Giugliano, 1996) .
In summary, we have demonstrated that in relatively wellcontrolled normolipemic T1DM patients with few cardiovascular risk factors the moderate postprandial Tg increase and a-tocopherol depletion are accompanied by an increase in lipid peroxidation in vivo but not by any increase in the susceptibility of lipoproteins to in vitro peroxidation. In view of the two main limitations of this study, namely the small subject number and the lack of a non-diabetic control group, further larger-scale studies focusing on the postprandial changes in in vivo lipid peroxidation are still required. By using more specific and accurate markers such as the currently accepted gold marker of peroxidation, F2 isoprostanes, these studies will determine to what extent these abnormalities are specific to T1DM, the impact of insulin therapy and the relevance of dietary interventions aimed at increasing antioxidant input or modifying the fat, glycation and peroxide composition of the meals.
